NEJMNew England Journal of Medicine NEJM Clinician NEJM Evidence NEJM AI NEJM Catalyst NEJM Voices

Loading...

Copyright © 2026

Massachusetts Medical Society.

All rights reserved, including those for text and data mining, AI training, and similar technologies.

Electronic ISSN 3067-1876

The content of this site is intended for health care professionals.

Journals

The New England Journal of Medicine

NEJM Catalyst Innovations in Care Delivery

About

About NEJM Clinician

Editors & Publishers

Editorial Policies

FOLLOW US

Copyright Terms Privacy Policy

NEJM Research Summary

Fremanezumab in Children and Adolescents with Episodic Migraine

New England Journal of Medicine

Feb 5

New England Journal of Medicine

February 5

New England Journal of Medicine

February 5

Topics